Unilever (UL) Stock Forecast, Price Target & Predictions
UL Stock Forecast
Unilever stock forecast is as follows: an average price target of $59.00 (represents a 2.38% upside from UL’s last price of $57.63) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
UL Price Target
UL Analyst Ratings
Buy
Unilever Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 22, 2024 | Victoria Petrova | Bank of America Securities | - | - | 16.50% | 24.93% |
Jul 26, 2024 | Taylor Conrad | Argus Research | - | - | 15.26% | 21.46% |
Dec 02, 2022 | Nick Setyan | Wedbush | - | - | -32.00% | -39.27% |
10
Unilever Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 2 |
Avg Price Target | - | $72.00 | $71.00 |
Last Closing Price | $57.63 | $57.63 | $57.63 |
Upside/Downside | -100.00% | 24.93% | 23.20% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 22, 2024 | Bank of America Securities | Buy | Upgrade | |
Jul 22, 2024 | Cowen & Co. | Buy | Initialise | |
Jul 22, 2024 | Jefferies | Underperform | Underperform | Hold |
Jul 01, 2024 | Jefferies | Underperform | Underperform | Hold |
Dec 02, 2022 | Wedbush | Neutral | Downgrade | |
Jul 26, 2022 | Deutsche Bank | Buy | Upgrade | |
May 31, 2022 | Morgan Stanley | Underweight | Downgrade | |
May 16, 2022 | Societe Generale | Sell | Downgrade |
10
Unilever Financial Forecast
Unilever Revenue Forecast
Quarter
Dec 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Jun 10 | Mar 07 | Jun 06 | Mar 05 | Jun 04 | Mar 03 | Dec 02 | Mar 97 | Mar 96 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.75B | $9.53B | $10.26B | $8.78B | $10.07B | $10.05B | $10.42B | $10.71B | $9.66B |
Avg Forecast | $30.08B | $16.14B | $37.16B | $28.34B | $33.39B | $36.81B | $29.82B | $25.50B | $25.07B | $22.07B | $18.29B | $19.13B | $16.40B | $15.59B | $11.20B | $10.91B | $9.55B | $8.16B | $10.68B | $7.88B | $8.25B | $5.57B | $8.43B | $9.33B | $10.57B | $9.10B | $7.55B |
High Forecast | $30.81B | $16.54B | $44.60B | $29.04B | $40.07B | $44.17B | $35.78B | $30.60B | $30.09B | $26.49B | $21.95B | $22.95B | $19.67B | $18.71B | $13.44B | $13.09B | $11.46B | $9.79B | $12.81B | $9.45B | $9.90B | $6.68B | $10.12B | $11.19B | $12.69B | $10.92B | $9.06B |
Low Forecast | $29.41B | $15.79B | $29.73B | $27.71B | $26.71B | $29.45B | $23.85B | $20.40B | $20.06B | $17.66B | $14.63B | $15.30B | $13.12B | $12.48B | $8.96B | $8.73B | $7.64B | $6.53B | $8.54B | $6.30B | $6.60B | $4.45B | $6.75B | $7.46B | $8.46B | $7.28B | $6.04B |
# Analysts | 4 | 6 | 12 | 9 | 16 | 12 | 13 | 19 | 17 | 12 | 14 | 14 | 13 | 17 | 17 | 13 | 19 | 19 | 8 | 12 | 9 | 20 | 10 | 19 | 8 | 18 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 1.21% | 1.24% | 1.58% | 1.19% | 1.08% | 0.99% | 1.18% | 1.28% |
Forecast
Unilever EBITDA Forecast
Quarter
Dec 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Jun 10 | Mar 07 | Jun 06 | Mar 05 | Jun 04 | Mar 03 | Dec 02 | Mar 97 | Mar 96 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 6 | 12 | 9 | 16 | 12 | 13 | 19 | 17 | 12 | 14 | 14 | 13 | 17 | 17 | 13 | 19 | 19 | 8 | 12 | 9 | 20 | 10 | 19 | 8 | 18 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.89B | $1.48B | $1.43B | $1.36B | $1.56B | $1.54B | $3.66B | $10.71B | $9.66B |
Avg Forecast | $5.98B | $3.21B | $5.99B | $5.63B | $5.38B | $5.69B | $4.80B | $4.11B | $4.04B | $3.56B | $2.95B | $3.08B | $2.64B | $2.51B | $1.80B | $1.76B | $1.54B | $1.31B | $1.69B | $1.27B | $1.07B | $922.63M | $1.14B | $1.12B | $506.37M | $353.49M | $305.65M |
High Forecast | $6.12B | $3.29B | $7.18B | $5.77B | $6.45B | $6.82B | $5.76B | $4.93B | $4.85B | $4.27B | $3.54B | $3.70B | $3.17B | $3.01B | $2.17B | $2.11B | $1.85B | $1.58B | $2.03B | $1.52B | $1.28B | $1.11B | $1.36B | $1.34B | $607.64M | $424.19M | $366.78M |
Low Forecast | $5.84B | $3.14B | $4.79B | $5.51B | $4.30B | $4.55B | $3.84B | $3.29B | $3.23B | $2.84B | $2.36B | $2.47B | $2.11B | $2.01B | $1.44B | $1.41B | $1.23B | $1.05B | $1.35B | $1.02B | $856.25M | $738.10M | $909.97M | $895.32M | $405.10M | $282.79M | $244.52M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | 1.17% | 1.34% | 1.48% | 1.37% | 1.38% | 7.23% | 30.31% | 31.59% |
Forecast
Unilever Net Income Forecast
Quarter
Dec 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Jun 10 | Mar 07 | Jun 06 | Mar 05 | Jun 04 | Mar 03 | Dec 02 | Mar 97 | Mar 96 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 6 | 12 | 9 | 16 | 12 | 13 | 19 | 17 | 12 | 14 | 14 | 13 | 17 | 17 | 13 | 19 | 19 | 8 | 12 | 9 | 20 | 10 | 19 | 8 | 18 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.06B | $1.01B | $986.81M | $934.00M | $1.02B | $610.08M | $-1.61M | $416.38M | $390.80M |
Avg Forecast | $3.39B | $3.58B | $3.95B | $3.01B | $3.55B | $3.25B | $3.17B | $2.71B | $2.67B | $2.35B | $1.94B | $2.03B | $1.74B | $1.66B | $1.19B | $1.16B | $1.02B | $867.85M | $964.79M | $837.56M | $793.38M | $591.85M | $851.03M | $566.30M | $232.21M | $353.49M | $305.65M |
High Forecast | $3.50B | $3.69B | $4.74B | $3.11B | $4.26B | $3.90B | $3.80B | $3.25B | $3.20B | $2.82B | $2.33B | $2.44B | $2.09B | $1.99B | $1.43B | $1.39B | $1.22B | $1.04B | $1.16B | $1.01B | $952.06M | $710.22M | $1.02B | $679.56M | $278.65M | $424.19M | $366.78M |
Low Forecast | $3.29B | $3.47B | $3.16B | $2.93B | $2.84B | $2.60B | $2.54B | $2.17B | $2.13B | $1.88B | $1.56B | $1.63B | $1.39B | $1.33B | $952.90M | $928.12M | $812.59M | $694.28M | $771.83M | $670.05M | $634.70M | $473.48M | $680.83M | $453.04M | $185.77M | $282.79M | $244.52M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 1.21% | 1.24% | 1.58% | 1.19% | 1.08% | -0.01% | 1.18% | 1.28% |
Forecast
Unilever SG&A Forecast
Quarter
Dec 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Jun 10 | Mar 07 | Jun 06 | Mar 05 | Jun 04 | Mar 03 | Dec 02 | Mar 97 | Mar 96 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 6 | 12 | 9 | 16 | 12 | 13 | 19 | 17 | 12 | 14 | 14 | 13 | 17 | 17 | 13 | 19 | 19 | 8 | 12 | 9 | 20 | 10 | 19 | 8 | 18 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $7.14B | $3.83B | $8.82B | $6.73B | $7.93B | $8.74B | $7.16B | $6.13B | $6.02B | $5.30B | $4.39B | $4.60B | $3.94B | $3.75B | $2.69B | $2.62B | $2.30B | $1.96B | $2.56B | $1.89B | $1.98B | $1.34B | $2.03B | $2.24B | $2.54B | $2.19B | $1.81B |
High Forecast | $7.32B | $3.93B | $10.59B | $6.89B | $9.51B | $10.49B | $8.60B | $7.35B | $7.23B | $6.36B | $5.27B | $5.51B | $4.73B | $4.50B | $3.23B | $3.15B | $2.75B | $2.35B | $3.08B | $2.27B | $2.38B | $1.60B | $2.43B | $2.69B | $3.05B | $2.62B | $2.18B |
Low Forecast | $6.98B | $3.75B | $7.06B | $6.58B | $6.34B | $6.99B | $5.73B | $4.90B | $4.82B | $4.24B | $3.51B | $3.68B | $3.15B | $3.00B | $2.15B | $2.10B | $1.84B | $1.57B | $2.05B | $1.51B | $1.59B | $1.07B | $1.62B | $1.79B | $2.03B | $1.75B | $1.45B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Unilever EPS Forecast
Quarter
Dec 24 | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Jun 10 | Mar 07 | Jun 06 | Mar 05 | Jun 04 | Mar 03 | Dec 02 | Mar 97 | Mar 96 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 6 | 12 | 9 | 16 | 12 | 13 | 19 | 17 | 12 | 14 | 14 | 13 | 17 | 17 | 13 | 19 | 19 | 8 | 12 | 9 | 20 | 10 | 19 | 8 | 18 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.35 | $0.34 | $32.09 | $0.24 | $0.21 | $-0.00 | $0.12 | $0.31 |
Avg Forecast | $1.35 | $1.42 | $1.87 | $1.20 | $1.68 | $1.84 | $1.51 | $1.28 | $1.27 | $1.11 | $0.92 | $0.96 | $0.83 | $0.79 | $0.57 | $0.55 | $0.48 | $0.41 | $0.49 | $0.40 | $0.38 | $0.21 | $0.34 | $0.26 | $0.30 | $0.13 | $0.12 |
High Forecast | $1.39 | $1.47 | $2.25 | $1.24 | $2.02 | $2.21 | $1.81 | $1.55 | $1.52 | $1.34 | $1.10 | $1.16 | $0.99 | $0.95 | $0.68 | $0.66 | $0.58 | $0.49 | $0.59 | $0.48 | $0.46 | $0.25 | $0.41 | $0.32 | $0.37 | $0.15 | $0.14 |
Low Forecast | $1.31 | $1.38 | $1.50 | $1.16 | $1.34 | $1.47 | $1.20 | $1.03 | $1.01 | $0.89 | $0.74 | $0.77 | $0.66 | $0.63 | $0.45 | $0.44 | $0.38 | $0.32 | $0.39 | $0.31 | $0.30 | $0.17 | $0.28 | $0.20 | $0.24 | $0.10 | $0.09 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 0.90% | 153.46% | 0.70% | 0.81% | -0.00% | 0.93% | 2.64% |
Forecast
Unilever Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
EL | Estée Lauder Companies | - | - | 152.09% | Hold |
COTY | Coty | - | - | 71.77% | Buy |
ELF | e.l.f. Beauty | - | - | 16.91% | Buy |
KMB | Kimberly-Clark | - | - | 5.55% | Hold |
UL | Unilever | - | - | 2.38% | Buy |
CHD | Church & Dwight | - | - | -0.12% | Hold |
CL | Colgate-Palmolive Company | - | - | -0.64% | Buy |
KVUE | Kenvue | - | - | -4.52% | Hold |
PG | Procter & Gamble Company | - | - | -7.33% | Buy |
CLX | Clorox Company | - | - | -12.05% | Buy |